NPI registry status
Active
2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1588983266 M.D.
Verify on CMS → Amandeep Mahal, M.D.
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in Omaha, Nebraska.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 621 in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 318 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 661
Generic prescribing
65%
generic claims · 35% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$862.57
31 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Amandeep Mahal, M.D. filed 1,270 Medicare Part D claims in 2024 as a Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in Omaha, Nebraska, prescribing 65% generic.
- 1K
- Part D claims, 2024
- 65%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥78th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Amandeep Mahal, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1588983266), first enumerated 05/20/2010.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,270 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$862.57 in reported industry payments (31 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1588983266 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
NPI-10 · ENUM-MID · TAX-NARROW · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1588983266
- ENUM-MID 2010
- TAX-NARROW 621
- RX-MID 1,270
- BOOK-THIN 3 in Nebraska
- PHOTO-ENUM Katie Propst · 2010
Amandeep Mahal, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,270 ≥ 78th percentile 78% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Amandeep Mahal, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Amandeep Mahal, M.D.?
Quality data not reportedPrimary specialty
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Medicare Part D claims
1,270 92% vs specialty avg
Specialty distribution in Nebraska
How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among Nebraska providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1588983266 |
|---|---|
| Specialty | Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/20/2010 |
Hospital and facility affiliations
Facilities where Amandeep Mahal, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Adult And Pediatric Urology PC
Omaha, NE
Urology Center PC
Omaha, NE
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Amandeep Mahal, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$863
Largest payer
Caldera Medical, Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Amandeep Mahal, M.D. - brand share 35.0%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician average
35% brand-name claims vs 65% generic, on 1,270 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,270
Total Claims
$298K
Total Drug Cost
318
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,763.533
- Total Day Supply
- 47,806
- Brand vs Generic
- 35% brand / 65% generic
- Brand Drug Cost
- $264K
- Generic Drug Cost
- $33K
- Antibiotic Claims
- 218
Patient Demographics
- Average Patient Age
- 73.7 years
- Avg HCC Risk Score
- 1.37
- Gender Split
- 100% female / 0% male
- Age Distribution
- <65: 38, 65-74: 127, 75-84: 115, 85+: 38
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Amandeep Mahal, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Methenamine Hippur…
Methenamine Hippurate
235 claims
- Gemtesa
Gemtesa
216 claims
- Myrbetriq
Myrbetriq
203 claims
- Trospium Chloride
Trospium Chloride
126 claims
- Sulfamethoxazole-T… 64
Sulfamethoxazole-Trimethoprim
64 claims
- Estradiol 62
Estradiol
62 claims
- Nitrofurantoin Mon… 62
Nitrofurantoin Mono-Macro
62 claims
- Nitrofurantoin 45
Nitrofurantoin
45 claims
| Drug | Claims |
|---|---|
| Methenamine Hippurate | 235 |
| Gemtesa Vibegron | 216 |
| Myrbetriq Mirabegron | 203 |
| Trospium Chloride | 126 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 64 |
| Estradiol | 62 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 62 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 45 |
| Tamsulosin Hcl | 31 |
| Oxybutynin Chloride | 25 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in NE →
All providers in Nebraska →
Compare specialties →
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview
How Amandeep Mahal, M.D. fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.
621
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
50
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
661
Avg Claims per Provider
Amandeep Mahal, M.D.'s 1,270 claims are above the specialty average of 661.
Nationwide Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Mahal, both outside Nebraska so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2010)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in Nebraska
Other clinicians with the same primary specialty enrolled in Nebraska, drawn from the same CMS NPPES roster as Mahal.
One of 3 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers enrolled in Nebraska, 2 are shown here.
Frequently Asked Questions
What is Amandeep Mahal, M.D.'s specialty? ▼
Amandeep Mahal, M.D. specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in Omaha, Nebraska. Credentials: M.D..
How much does Amandeep Mahal, M.D. prescribe under Medicare Part D? ▼
In 2024, Amandeep Mahal, M.D. wrote 1,270 Medicare Part D claims totaling $298K in drug costs for 318 beneficiaries.
Where is Amandeep Mahal, M.D. located? ▼
Amandeep Mahal, M.D. is located at 10707 PACIFIC ST STE 101, Omaha, NE, 68114. Phone: (402) 397-7989.
What is Amandeep Mahal, M.D.'s NPI number? ▼
Amandeep Mahal, M.D.'s National Provider Identifier (NPI) is 1588983266, issued on 05/20/2010.
Does Amandeep Mahal, M.D. prescribe more brand-name or generic drugs? ▼
Amandeep Mahal, M.D.'s prescribing is 35% brand-name and 65% generic drugs by claim count, with $264K in brand drug costs.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US? ▼
There are 621 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 50 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 661 Medicare Part D claims per year.
What drugs does Amandeep Mahal, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Amandeep Mahal, M.D.'s most frequently prescribed drugs include Methenamine Hippurate, Gemtesa, Myrbetriq. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Amandeep Mahal, M.D. accept Medicare? ▼
Amandeep Mahal, M.D. appears in CMS Medicare data with 1,270 Part D claims and 318 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Amandeep Mahal, M.D.'s credentials? ▼
Amandeep Mahal, M.D.'s NPI is 1588983266 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.